Back to Journals » OncoTargets and Therapy » Volume 9

Review

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence

       
Total article views   HTML views PDF downloads Totals
15,494 Dovepress* 12,927+ 1,797 14,724
PubMed Central* 2,567 1,087 3,654
Totals 15,494 2,884 18,378
*Since 6 September 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar